A seven-nuclear receptor-based prognostic signature in breast cancer
Authors:
- 18 November 2020
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 23 (7) , 1292-1303
Abstract
Background Breast cancer (BRCA) is a malignant cancer that threatened the life of female with unsatisfactory prognosis. The aim of this study was to identify prognostic nuclear receptors (NRs) signature of BRCA. Methods BRCA patient samples were collected from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database. Consensus clustering analysis, univariate Cox regression analysis and the least absolute shrinkage and selection operator (LASSO) Cox regression analysis were performed to evaluate, select NRs as prognostic factors and build Risk Score model. GSEA analysis was explored to check signaling differences between High- and Low-Risk group. Nomogram model basing on age and Risk Score was established to predict the 1-, 3- and 5-year survival. Model performance was assessed by a time-dependent receiver operating characteristic (ROC) curve and calibration plot. CIBERSORT, ESTIMATE and TIMER algorithm were introduced to evaluate the immune landscape. Results NR3C1, NR4A3, THRA, RXRG, NR2F6, NR1D2 and RORB were optimized as a prognostic signature for BRCA. This seven-NR-based Risk Score could effectively predict overall survival status. The area under the curve (AUC) of 1-, 3- and 5-year overall survival are 0.702, 0.734 and 0.722 in TCGA training cohort, and 0.630, 0.721 and 0.823 in GEO validation cohort, respectively. Calibration plot demonstrated satisfactory agreement between predictive and observed outcomes. Nomogram model worked well on predicting survival probabilities. Multiple cancer-related pathways were highly enriched in High-Risk group. High- and Low-Risk groups showed significant differed immune cell infiltration. There exists an obvious connection between Risk Score and immune checkpoints LAG3, PD1 and TIM3. Conclusion The seven-NR-based Risk Score represents a promising signature for estimating overall survival in patients with BRCA, and is correlated with the immune microenvironment.Keywords
This publication has 47 references indexed in Scilit:
- Pan-cancer analyses of human nuclear receptors reveal transcriptome diversity and prognostic value across cancer typesScientific Reports, 2020
- Breast Cancer: Current Perspectives on the Disease Status2019
- Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasisCellular Oncology, 2018
- Nuclear receptors in cancer — uncovering new and evolving roles through genomic analysisNature Reviews Genetics, 2017
- Nuclear receptors in neural stem/progenitor cell homeostasisCellular and Molecular Life Sciences, 2017
- Mechanisms involved in breast cancer liver metastasisJournal of Translational Medicine, 2015
- An evolving understanding of nuclear receptor coregulator proteinsJournal of Molecular Endocrinology, 2013
- Breast cancerThe Lancet, 2005
- Ligand binding and nuclear receptor evolutionBioEssays, 2000
- The nuclear receptor superfamily: The second decadeCell, 1995